DermTech

$12.65
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.04 (+8.96%) Today

$0.00 (0.00%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell DermTech and other stocks, options, and ETFs commission-free!

About DMTK

DermTech, Inc. Common Stock, also called DermTech, is a genomics company in dermatology, which engages in the development and sale of products for the diagnosis and treatment of skin diseases. It markets and develops products that facilitate the early detection of skin cancers, assesses inflammatory diseases, and customizes drug treatments. Its products include adhesive skin collection kit, pigmented lesion assay, nevome, and carcinome. The company was founded in 1995 and is headquartered in La Jolla, CA. The listed name for DMTK is DermTech, Inc. Common Stock.

CEO

John D. Dobak

Employees

—

Headquarters

La Jolla, California

Founded

1995

Market Cap

247.88M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

170.18K

High Today

$12.82

Low Today

$11.49

Open Price

$11.55

Volume

200.13K

52 Week High

$16.95

52 Week Low

$7.47

Collections

DMTK Earnings

-$0.93

-$0.62

-$0.31

-$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 9, After Hours